Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Insulet Corp (NQ: PODD )

318.96 +2.08 (+0.66%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 31, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 895,436
Open 318.78
Bid (Size) 309.06 (2)
Ask (Size) 330.68 (1)
Prev. Close 316.88
Today's Range 318.31 - 324.18
52wk Range 181.00 - 326.74
Shares Outstanding 68,873,869
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Insulet to Announce First Quarter 2023 Financial Results on May 4, 2023
From Insulet Corporation
Via Business Wire
Analyst Expectations for Insulet's Future
 
Via Benzinga

Performance

YTD
+11.38%
+11.38%
1 Month
+12.91%
+12.91%
3 Month
+8.35%
+8.35%
6 Month
+39.04%
+39.04%
1 Year
+19.73%
+19.73%

More News

Read More
CORRECTING and REPLACING Insulet Reports Full Year 2022 Revenue Increase of 19% (22% constant currency1) and Fourth Quarter 2022 Revenue Increase of 20% Year-Over-Year (24% constant currency)
From Insulet Corporation
Via Business Wire
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Preview: Insulet's Earnings
Via Benzinga
2 Best Medical Device Stocks for 2023
Via The Motley Fool
Looking Into Insulet's Return On Invested Capital
Via Benzinga
Earnings Scheduled For February 23, 2023
Via Benzinga
Highly Anticipated Omnipod® 5 Real-World Evidence to be Presented at the 16th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD)
From Insulet Corporation
Via Business Wire
3 Growth Stocks That Have Delivered 10X Returns Over the Past Decade
Via The Motley Fool
Insulet Acquires Assets of Automated Glucose Control LLC (AGC)
From Insulet Corporation
Via Business Wire
Insulet to Present at Upcoming Investor Conferences
From Insulet Corporation
Via Business Wire
Insulet Acquires Insulin Pump Patents from Bigfoot Biomedical as Both Companies Prioritize Improved Insulin Delivery Technologies
From Insulet Corporation
Via Business Wire
The 7 Best Tech Stocks to Buy for February 2023
Via InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For January 26, 2023
Via Benzinga
Insulet Has Potential To Gain More Than Analysts Are Forecasting
Via MarketBeat
Insulet to Announce Fourth Quarter and Full Year 2022 Financial Results on February 23, 2023
From Insulet Corporation
Via Business Wire
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Dow Jones Giant UnitedHealth Among 5 Resilient Stocks In Sickly Market Rally
Via Investor's Business Daily
Insulet to Present at Upcoming Investor Conferences
From Insulet Corporation
Via Business Wire
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Insulet Issues Medical Device Correction For Omnipod 5 Controller Due To Faulty Charging
Via Benzinga
Insulet Issues a Nationwide Voluntary Medical Device Correction for the Omnipod® 5 Controller
From Insulet Corporation
Via Business Wire
Why MediaAlpha Shares Jumped Around 30%; Here Are 112 Biggest Movers From Friday
Via Benzinga
Insulet Issued Voluntary Medical Device Correction for Omnipod DASH® Personal Diabetes Manager on October 17, 2022
From Insulet Corporation
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.